The GLP-1 shortages are over. What happens next?
Tirzepatide is approved by the Food and Drug Administration (FDA) for treating type 2 diabetes and obesity, akin to other GLP ...
Millions of people are taking compounded weight loss drugs. Now, they're about to disappear.
Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...
The FDA Cracking Down on Compounded Weight Loss Drugs – Here’s What It Means for Telehealth Companies and Consumers
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
FingerLakes1.com18h
GLP-1 Therapy: Unlocking the Potential of Modern Weight Loss Solutions
GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...
New ‘natural’ GLP-1 booster that can be added to any food for weight loss to hit shelves within the next year
NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...
Drug Delivery Business19h
Vivani reports first human GLP-1 implant for weight loss in adults
Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 ...
Ask the doctors: GLP-1 microdosing is experimental and unauthorized
I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic.
The Ozempic workout? How gyms and trainers are catering to a new group of exercisers
With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...
GlobalData on MSN19h
Vivani treats first patient with long-lasting drug implant for weight loss
A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the ...
Thank God I’ve stopped microdosing Ozempic – this is what it’s really like
The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says Charlotte ...
Medical Marketing & Media21h
Roche strikes $5.3B obesity treatment deal with Zealand Pharma
Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...